Author

Leila Valanejad

University of Rhode Island - Cited by 568

Biography

Leila Valanejad is currently working in the Division of Pediatric General and Thoracic Surgery, Cincinnati Children’s Hospital Medical Center, USA. Leila Valanejad international experience includes various programs, contributions and participation in different countries for diverse fields of study. Leila Valanejad research interests reflect wide range of publications in various national and international journals.
Title
Cited by
Year
Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy
X Song, A Vasilenko, Y Chen, L Valanejad, R Verma, B Yan, R DengHepatology 60 (6), 1993-2007, 2014201
101
2014
Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma
Y Chen, X Song, L Valanejad, A Vasilenko, V More, X Qiu, W Chen, Y Lai, ...Hepatology 57 (4), 1530-1541, 2013201
84
2013
Activation of CDK4 triggers development of non-alcoholic fatty liver disease
J Jin, L Valanejad, TP Nguyen, K Lewis, M Wright, A Cast, L Stock, ...Cell reports 16 (3), 744-756, 2016201
48
2016
Estrogen and estrogen receptor-α-mediated transrepression of bile salt export pump
Y Chen, A Vasilenko, X Song, L Valanejad, R Verma, S You, B Yan, ...Molecular Endocrinology 29 (4), 613-626, 2015201
45
2015
C/EBPα‐dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer
A Cast, L Valanejad, M Wright, P Nguyen, A Gupta, L Zhu, S Shin, ...Hepatology 67 (5), 1857-1871, 2018201
40
2018
Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor
X Song, Y Chen, L Valanejad, R Kaimal, B Yan, M Stoner, R DengJournal of lipid research 54 (11), 3030-3044, 2013201
38
2013
Elimination of age-associated hepatic steatosis and correction of aging phenotype by inhibition of cdk4-C/EBPα-p300 axis
P Nguyen, L Valanejad, A Cast, M Wright, JM Garcia, HB El-Serag, ...Cell reports 24 (6), 1597-1609, 2018201
37
2018
FXR-Gankyrin axis is involved in development of pediatric liver cancer
L Valanejad, K Lewis, M Wright, Y Jiang, A D’Souza, R Karns, R Sheridan, ...Carcinogenesis 38 (7), 738-747, 2017201
31
2017
PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma
L Valanejad, A Cast, M Wright, KD Bissig, R Karns, MT Weirauch, ...Communications Biology 1 (1), 67, 2018201
30
2018
RNA binding protein CUGBP1 inhibits liver cancer in a phosphorylation-dependent manner
K Lewis, L Valanejad, A Cast, M Wright, C Wei, P Iakova, L Stock, R Karns, ...Molecular and cellular biology 37 (16), e00128-17, 2017201
26
2017
Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1
C Wei, L Stock, L Valanejad, ZA Zalewski, R Karns, J Puymirat, D Nelson, ...The FASEB Journal 32 (4), 2073, 2018201
24
2018
Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: implications and mechanisms
L Valanejad, M Ghareeb, S Shiffka, C Nadolny, Y Chen, L Guo, R Verma, ...Molecular and Cellular Endocrinology 470, 127-141, 2018201
21
2018
p300 regulates liver functions by controlling p53 and C/EBP family proteins through multiple signaling pathways
M Breaux, K Lewis, L Valanejad, P Iakova, F Chen, Q Mo, E Medrano, ...Molecular and Cellular Biology 35 (17), 3005-3016, 151
20
2015
Gankyrin promotes tumor-suppressor protein degradation to drive hepatocyte proliferation
AM D’Souza, Y Jiang, A Cast, L Valanejad, M Wright, K Lewis, M Kumbaji, ...Cellular and molecular gastroenterology and hepatology 6 (3), 239-255, 2018201
15
2018
Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids
Differential Feedback Regulation of Δ4-3-Oxosteroid β-Reductase Expression by Bile AcidsL Valanejad, C Nadolny, S Shiffka, Y Chen, S You, R DengPloS one 12 (1), e0170960, 2017201
5
2017
Akt‐FoxO1 axis controls liver regeneration
L Valanejad, N TimchenkoHepatology 6 (5), 1424-1426, 2016201
3
2016